“We believe this acquisition will drive incremental growth in both the Eagle Labs business and the existing Innovia platform as we capitalize on channel leverage and cross-selling opportunities,” Don Pierce, partner of Shore Capital and chairman of the board of Innovia, said in the release. “The addition of Eagle Labs broadens Innovia’s product offering and positions Innovia as a key player of scale in the industry.”

Eagle manufactures and distributes ophthalmic cannulas, knives and blades, as well as provides high- and low-volume contract assembly and packaging, and sterilization for single-use medical devices, the release said.

“We believe this acquisition will drive incremental growth in both the Eagle Labs business and the existing Innovia platform as we capitalize on channel leverage and cross-selling opportunities,” Don Pierce, partner of Shore Capital and chairman of the board of Innovia, said in the release. “The addition of Eagle Labs broadens Innovia’s product offering and positions Innovia as a key player of scale in the industry.”

Eagle manufactures and distributes ophthalmic cannulas, knives and blades, as well as provides high- and low-volume contract assembly and packaging, and sterilization for single-use medical devices, the release said.